-

Biogennix Launches Clinical-Strength Hand Sanitizer

Biogennix Partners with California-Based SafeRacks to Help Fight Spread of Coronavirus

IRVINE, Calif.--(BUSINESS WIRE)--Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, has teamed with Rancho Santa Margarita, California based provider of the storage product SafeRacks®, to develop and launch a new line of clinical-strength hand sanitizer in an effort to proactively assist the community in preventive measures to help combat COVID-19.

The new sprayable, quick-drying sanitizer product is made with an 80% ethanol alcohol formulation recommended by the World Health Organization. The hand sanitizer is fully manufactured in the United States and ships from Biogennix’s facility in Irvine. The product is available for national distribution through SafeRacks via the SafeRacks.com site, as well as on Biogennix’s website (www.biogennix.com).

Despite the COVID-19 pandemic and its effects on the healthcare sector globally, Biogennix has remained functional while taking all necessary measures to keep its team safe. Biogennix continues to supply its existing products to customers, including its newly FDA-approved Agilon moldable bone grafting product. In addition to preparing for the resurgence of elective surgeries that were postponed due to the pandemic, Biogennix chose to use its available production resources to produce a high quality, hand sanitizer product that would quickly be made available to healthcare workers at the front lines of the battle against the coronavirus, as well as to the public.

“We wanted to contribute with our available resources to do something impactful, so we created a product we know is in high demand right now,” said Michael Roux, Biogennix’s General Manager. “This is top-of-the-line sanitizer, provided in individual spray bottles and one-gallon jugs, fully made and manufactured here in California and ready for distribution to essential workers and the general population as well.”

Both SafeRacks and Biogennix are Veteran-owned businesses.

Biogennix designs, manufactures and distributes all of its products from its Irvine-based facilities.

Biogennix® is a fully-integrated osteobiologics company headquartered in Irvine which develops, manufactures, and distributes proprietary bone grafting products used in bone fusion procedures. Biogennix is committed to advancing technology behind natural bone grafting solutions, delivering outstanding quality with exceptional value, and customer-focused excellence. Learn more at biogennix.com.

SafeRacks® is a leading provider of home and commercial storage products and has become one of America's most trusted storage & organization brands; making Inc. 500‘s top fastest growing US businesses. SafeRacks provides a comprehensive lineup of overhead storage racks, shelving and premium storage cabinets. Since their inception, SafeRacks has helped over one million homes and businesses with their nationwide network of professional installers in 45 markets across the country. Learn more at www.SafeRacks.com

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com

Biogennix


Release Summary
Biogennix has teamed with SafeRacks to produce and distribute a new clinical-strength hand sanitizer, which is now available to the general public.
Release Versions

Contacts

Paul Williams, 310-569-0023, paul@medialinecommunications.com

More News From Biogennix

Biogennix Launches Agilon Surgical Matrix

IRVINE, Calif.--(BUSINESS WIRE)--Biogennix, an osteobiologics company specializing in innovative healing solutions for surgical procedures, has announced the launch of its new Agilon Surgical Matrix wound care product. Agilon Surgical Matrix is a wound care solution derived from 100% bovine Type 1 collagen. Upon contact with a new or open wound, whether surgically or naturally occurring, Agilon Surgical Matrix transforms into a gel, enveloping the entire wound area. This coverage maintains a lo...

Biogennix Announces Publication of a Scientific Study on Its Advanced Bone Graft Technology

IRVINE, Calif.--(BUSINESS WIRE)--Biogennix, an osteobiologics company specializing in products for bone graft procedures, has announced the publication of a detailed scientific study characterizing multiple advanced properties of its TrelCor bone graft material. TrelCor is an innovative dual-phase bone graft featuring a nanocrystalline hydroxycarbanoapatite (HCA) surface, specially engineered for bone formation. The study, titled “Characterization of an Advanced Bone Graft Material with a Nanoc...

Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products

IRVINE, Calif.--(BUSINESS WIRE)--Irvine-based Biogennix, LLC an osteobiologics company specializing in bone graft products for fusion procedures, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an expanded indication for its Agilon Moldable and Morpheus Moldable bone grafting products. The new clearance allows the products to be used in the intervertebral disc space as an autograft extender, with an FDA-cleared intervertebral body fusion device...
Back to Newsroom